• SENSEX 77,235.46
    -492.70 (--0.63%)
  • BANKNIFTY 57,497.80
    6.70 (+0.01%)
  • Billionbrains
    190.70 112.02(%)
  • Lenskart Solut.
    638.00 627.35(%)
  • Cupid
    285.50 298.95(%)
  • Embassy Off.REIT
    438.80 375.00(%)
  • ICICI Pru Life
    500.60 459.60(%)
  • Dhoot Transmission
    1,306.25 1,212.70(%)
  • Netweb Technol.
    5,398.00 5,272.55(%)
  • ICICI Lombard
    1,615.00 1,544.40(%)
  • Molbio Diagnosti
    1,175.00 1,064.85(%)
  • Max Healthcare
    1,016.50 1,258.95(%)
  • Cyient
    850.00 751.00(%)
  • Multi Comm. Exc.
    3,057.10 3,479.80(%)
  • P I Industries
    2,542.40 3,916.00(%)
  • Jindal Steel
    1,101.90 943.50(%)
  • Baazar Style
    403.65 426.85(%)
  • Sun Pharma.Inds.
    1,868.50 1,547.25(%)
  • Schaeffler India
    4,099.00 4,465.00(%)
  • Reliance Industries
    1,328.00 1,611.20(%)
  • Dixon Technolog.
    14,420.80 18,471.50(%)
  • Paras Defence
    1,527.65 1,444.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Trident Lifeline Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 77345.0
  • ISIN : INE0MKA01014
272.25 8 (3.20%)
  • As on 18 Aug 2026 (EOD)

  • Today’s Low

    266.15

  • Today’s High

    280.00

  • Open

    266.15

  • Perv Close

    263.80

  • 52W Low

    229.95

  • 52W High

    328.00

Key Indicators

  • P/E(TTM)

    16.55

  • Mar.Cap (₹Cr.)

    324.88

  • Div & Yield %

    0.00

  • Book Value(₹)

    83.03

  • Debt-Equity Ratio

    3.20

  • AGM Date

    17-Aug-2026

  • EPS

    16.45

  • P/E Ratio

    16.55

Financials Ratios

  • Debt-Equity Ratio

    0.26

  • Mar.Cap (₹Cr.)

    324.88

  • RONW (%)

    12.06

  • ROCE (%)

    14.99

Score Board

  • Equity (₹ in Cr.)

    11.93

  • BV (₹)

    83.00

  • Sales( ₹ in Cr.)

    101.90

  • NP (in Cr.)

    18.09

  • NP Var(%)

    39.0

  • Div%

    0.0

  • CPS (₹)

    16.70

  • EPS (₹)

    15.20

  • Traded Value (₹ in Lakhs)

    324.88

  • 52 Week High

    328.00

  • 52 Week Low

    229.95

  • Price BSE

    272.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    324.88

  • P/C Ratio

    16.30

  • P/E Ratio

    17.90

  • Price Vs.BV

    15.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 67.80 44.65 31.69 21.77 9.62 4.93
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 67.80 44.65 31.69 21.77 9.62 4.93
Other Income 3.14 2.20 1.15 0.60 0.16 0.07
Stock Adjustments -1.47 0.67 2.89 0.46 0.41 0.09
Total Income 69.47 47.52 35.73 22.83 10.19 5.09
EXPENDITURE :            
Raw Materials 34.74 30.23 23.12 14.69 5.92 3.40
Power and Fuel Cost 0.14 0.07 0.03 0.02 0.02 0.02
Employee Cost 2.51 1.55 1.39 1.10 0.70 0.71
Other Manufacturing Expenses 8.73 2.54 2.38 2.66 1.29 0.38
Selling and Administration Expenses 1.76 1.36 0.98 0.94 0.83 0.78
Miscellaneous Expenses 0.79 0.70 0.42 0.11 0.01 0.01
Employee Benefit Expenses 2.51 1.55 1.39 1.10 0.70 0.71
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 48.66 36.45 28.33 19.52 8.78 5.30
Operating Profit 20.81 11.08 7.42 3.32 1.41 -0.20
Interest 1.38 0.51 0.48 0.13 0.41 0.76
Gross Profit 19.43 10.57 6.94 3.19 1.00 -0.96
Depreciation 1.53 0.77 0.36 0.20 0.14 0.12
Profit Before Tax 17.90 9.80 6.58 2.99 0.86 -1.08
Current Tax 4.25 2.38 0.04 -0.14 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.60 0.37 0.52 -0.82 0.22 -0.28
Reported Net Profit 13.05 7.04 6.01 3.95 0.63 -0.80
Extraordinary Items 0.00 0.01 0.00 0.00 0.00 0.01
Adjusted Net Profit 13.05 7.03 6.01 3.95 0.63 -0.81
Adjustment below Net Profit 0.00 0.00 -0.50 0.00 -0.63 2.60
P & L Balance brought forward 9.33 2.29 -3.22 -7.17 -6.10 -7.11
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 -0.63 0.80
P & L Balance carried down 22.38 9.33 2.29 -3.22 -5.47 -6.10
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 11.35 6.13 5.23 4.93 1.26 -2.57
Earnings Per Share(Adj)-Unit Curr 11.35 6.13 5.23 - - -
Book Value 57.16 45.81 39.68 5.97 -0.94 -9.69
Book Value(Adj)-Unit Curr 57.16 45.81 39.68 - - -

Shareholding Pattern

  • Promoter Group

    62.59%

  • Public Share Holding

    37.41%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 65,200 65,200.00 65,200 65,200
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 65,200 0.55 65,200 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 109,300 0.92 109,300 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 6,436,534 53.94 6,436,534 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 857,366 7.18 857,366 1
Others 0 0.00 0 0
Sub Total 7,403,200 62.04 7,403,200 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 627,000 5.25 627,000 5
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 31,200 0.26 31,200 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 658,200 5.52 658,200 6
2] Non Institution
Bodies Corporate 652,200 5.47 652,200 11
Clearing Members 67,800 0.57 67,800 4
Directors of their Relatives 90,600 0.76 90,600 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 33,600 0.28 33,600 17
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 397,200 3.33 397,200 48
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,019,400 8.54 1,019,400 24
Individuals holding nominal share capital up to Rs. 1 lakh 1,437,000 12.04 1,437,000 584
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 30,600 0.26 30,600 1
Sub Total 3,806,400 31.90 3,806,400 691
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,933,000 100.00 11,933,000 709

Company Background

Trident Lifeline LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Trident Lifeline Ltd
  • BSE Code : 77345.0
  • ISIN : INE0MKA01014

  • Incorporation Year

    2014

  • Registered Office

    2nd Floor Shop 2004 North Ext.
    Falsawadi Begumpura Nodh4/1650, Surat,
    Gujarat-395003

  • Telephone

    91-0261-2490224/8160276395

  • FAX

  • Chairman

    Hardik J Desai

  • Managing Director

  • Company Secretary

    Nikita Sharma

  • Auditor

    A Bafna & Associates.

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Trident Lifeline Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Trident Lifeline 272.25 70.94 67.80 16.55 27.61
Abbott India 26,933.65 7,217.19 6,929.05 35.45 43.78
Astrazeneca Phar 7,628.85 2,304.07 2,275.58 112.44 27.86
Glaxosmi. Pharma 2,699.80 3,932.76 3,790.20 43.13 58.17
Novartis India 1,589.20 398.23 356.27 40.13 16.64
Cipla 1,430.00 20,102.60 18,979.95 37.58 13.88
Bliss GVS Pharma 519.50 773.53 729.81 48.24 12.51
Amrutanjan Healt 492.55 469.50 451.82 26.38 21.89
Fermenta Biotec. 458.25 474.15 450.25 21.39 18.77
Guj. Themis Bio. 352.80 152.47 150.80 78.93 27.21
Ambalal Sarabhai 45.69 19.52 3.94 84.61 6.77